Patents Examined by Jeffrey S. Parkin, Ph.D.
  • Patent number: 5627025
    Abstract: The present invention relates to the role of dendritic cells in facilitating productive human immunodeficiency virus (HIV) infection. Experimentally, productive infection with HIV-1 requires that virus be administered to T cells that are activated by mitogens. This application describes a productive milieu for HIV-1 infection within the confines of normal epithelial tissue that does not require standard stimuli. The milieu consists of dendritic cells and T cells that emigrate from skin and produce distinctive stable, nonproliferating conjugates. These conjugates, upon exposure to HIV-1, begin to release high levels of virus progeny. Numerous infected syncytia, comprised of both dendritic cells and T cells, rapidly develop. A method is disclosed for the identification of agents capable of inhibiting HIV transmission and chronic infection of dendritic cells and T lymphocytes found in epithelial tissues.
    Type: Grant
    Filed: August 12, 1994
    Date of Patent: May 6, 1997
    Assignee: The Rockefeller University
    Inventors: Ralph M. Steinman, Melissa Pope, Michiel Betjes, Lloyd Hoffman